FDA warning letter · Drugs

Latin Foods Market

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

FDA confirmed through laboratory analysis that a sample of your “Artri King Reforzado con Ortiga y Omega 3” contains the undeclared active pharmaceutical ingredients diclofenac and dexamethasone, which are not listed on the product label.

Passage 2

“Artri King Reforzado con Ortiga y Omega 3” is a drug as defined by section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1) because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or any function of the body.

Passage 3

“Artri King Reforzado con Ortiga y Omega 3” is not generally recognized as safe and effective for its above referenced uses and therefore is a “new drug” under section 201(p) of the FD&C Act, 21 U.S.C. 321(p).

Passage 4

The labeling for “Artri King Reforzado con Ortiga y Omega 3” does not declare that the product contains the drug ingredients diclofenac and dexamethasone.